ArticleJAMA network open2022

Comparative Safety of the BNT162b2 Messenger RNA COVID-19 Vaccine vs Other Approved Vaccines in Children Younger Than 5 Years.

Nicole Toepfner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.